Strategic imperatives for biotech firms in light of the latest market dynamics and investor behaviors.
Divya Yerraguntla
Advertisement
Vice President, Asset Strategy, Syneos Health
Articles by Divya Yerraguntla
Choosing the right team and implementing structure headline necessities for launch.
Advertisement
Latest Updated Articles
How Should Biotechs Strategize for 2025Published: August 12th 2024 | Updated: February 13th 2025
Advertisement
Advertisement
Trending on PharmExec
1
Technological Renaissance: AI’s Integration into the Pharmaceutical Industry
2
AI's Inflection Point: Bridging the Adoption and ROI Gap
3
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
4
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
5